Bloodless Surgery in a Jehovah’s Witness Patient with a 12.7-kg Uterine Leiomyosarcoma
Introduction
Bloodless surgery aims to optimize outcomes in patients undergoing surgical procedures who wish to avoid allogeneic transfusion. Using a series of interventions and management strategies related to this goal, patients who were previously considered extremely high risk or inoperable without a blood transfusion can now undergo complex surgical procedures with acceptable outcomes. The techniques of bloodless surgery have been incorporated in order to care for a patient with a large uterine sarcoma with involvement and invasion into adjacent organs.
Case
A 52-year-old female Jehovah’s Witness patient refusing allogeneic blood transfusion presented to the gynecologic oncology division with a 40-cm pelvic mass and anemia. She was enrolled into the bloodless surgery program at the authors’ institution and subsequently underwent surgical resection of a 12.7-kg uterine leiomyosarcoma. Although her intraoperative course was significant for severe anemia with a hemoglobin of 2.5 g/dl and her postoperative course required long-term hospitalization, the patient regained full function to her preoperative performance status.
Conclusions
Bloodless surgery in patients with a potential for large-volume intraoperative blood loss requires a well-organized systematic, multidisciplinary approach to achieve the best possible outcome
Key Words: uterine leiomyosarcoma, Jehovah’s Witness, anemia, bloodless surgery
Competency: Patient Care, Medical Knowledge, Systems Based Practice
To access this article, please choose from the options below
PII: S1931-7204(07)00108-0
doi:10.1016/j.jsurg.2007.03.008
© 2007 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.
